Alerts will be sent to your verified email
Verify Email
FDC
|
FDC
|
Torrent Pharma
|
Sanofi India
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
Domestic Sales Growth - YoY
|
5.7 % | 11.1 % | -1.2 % |
|
R&D as a % of Total Sales
|
2.23 % | 5.0 % | 0.0 |
|
Financials
|
|||
|
5 yr Average ROE
|
13.1 % | 17.02 % | 43.25 % |
|
5yr average Equity Multiplier
|
1.55 | 2.5 | 3.33 |
|
5yr Average Asset Turnover Ratio
|
0.52 | 0.61 | 0.57 |
|
5yr Avg Net Profit Margin
|
16.21 % | 11.26 % | 22.99 % |
|
Price to Book
|
3.69 | 13.49 | 19.69 |
|
P/E
|
25.1 | 60.57 | 33.16 |
|
5yr Avg Cash Conversion Cycle
|
-4.62 Days | -151.22 Days | 11.11 Days |
|
Inventory Days
|
57.02 Days | 54.43 Days | 48.47 Days |
|
Days Receivable
|
20.32 Days | 39.91 Days | 13.83 Days |
|
Days Payable
|
84.76 Days | 337.02 Days | 55.71 Days |
|
5yr Average Interest Coverage Ratio
|
106.56 | 4.68 | 1007.93 |
|
5yr Avg ROCE
|
14.86 % | 21.27 % | 29.56 % |
|
5yr Avg Operating Profit Margin
|
24.57 % | 29.61 % | 28.62 % |
|
5 yr average Debt to Equity
|
0.0 | 0.97 | 0.0 |
|
5yr CAGR Net Profit
|
2.71 % | 23.34 % | 41.96 % |
|
5yr Average Return on Assets
|
8.46 % | 6.93 % | 13.01 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
69.66 % | 71.25 % | 60.4 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.31 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
2.95 % | -2.01 % | 1.86 % |
|
FDC
|
Torrent Pharma
|
Sanofi India
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Therapeutic Area Wise Break-Up - Domestic
|
Therapeutic Area Wise Break-Up - Domestic
|
-
|
Therapeutic Area Wise Break-Up - Domestic
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
